Asthma and Chronic Obstructive Pulmonary Disease (COPD) affect the lives of over 5% of the population causing untold levels of personal distress due to the loss of control over one of the most basic aspects of life – being able to breathe. In the most severe cases, death can result – a growing problem with the WHO (World Health Organisation) predicting COPD will become the 3^rd leading cause of mortality by 2030.

For all patients the danger of a serious exacerbation is never far from their mind; however, the vast majority are still not consistently getting the medicine they need.

Mundipharma passionately believes that the next step in the treatment of respiratory diseases will come from products that will work with the patient. As such, we are committed to bringing together for the first time an integrated and consistent solution to all three cornerstones of treatment:

• Quick relief of the distressing symptoms
• Lasting control of the cause of the disease
• Simple and consistent delivery that all patients can take

Working with the industry’s leading experts we are progressing quickly towards delivering such an integrated solution and we are confident it will soon become a new industry standard.

In the coming months and years we will continue to work hard with healthcare specialists who, like us, want to make life simpler for patients.